ACAD
ACADIA Pharmaceuticals Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager): Halterbreite 0.0% · Aktienfluss +10.9% · neue Nettopositionen 0.0% — Formel
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q1 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 122 | +9 | 90.95M | $2.30B | +11 | −1 |
| Q1 2026 | 115 | -3 | 85.30M | $1.90B | +4 | −8 |
| Q4 2025 | 119 | 0 | 93.96M | $2.51B | +1 | — |
| Q3 2025 | 23 | +1 | 66.53M | $1.42B | +1 | −1 |
| Q2 2025 | 20 | +2 | 61.51M | $1.33B | +2 | — |
| Q1 2025 | 15 | 0 | 22.54M | $374.41M | — | — |
| Q4 2024 | 15 | +1 | 20.32M | $372.93M | +1 | — |
| Q3 2024 | 13 | -1 | 13.63M | $209.57M | — | −1 |
| Q2 2024 | 14 | — | 19.35M | $314.37M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passiv) | 6.99M | +54.7% | $116.16M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Point72 Asset Management ✦ | 4.65M | +108.3% | $77.20M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passiv) | 2.95M | +2.7% | $49.09M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passiv) | 2.95M | +2.7% | $49.09M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | D. E. Shaw & Co. ✦ | 2.35M | -27.5% | $39.02M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 2.35M | -27.5% | $39.02M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | Renaissance Technologies ✦ | 1.48M | +20.4% | $24.53M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | Norges Bank ✦ (passiv) | 1.42M | +2.0% | $23.60M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | Two Sigma Investments ✦ | 816.66K | -34.3% | $13.56M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 649.38K | +4.6% | $10.79M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 649.38K | +4.6% | $10.79M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 12 | Fisher Asset Management ✦ | 355.02K | +8.4% | $5.90M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | Marshall Wace ✦ | 330.40K | -66.8% | $5.49M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 14 | Marshall Wace ✦ | 330.40K | -66.8% | $5.49M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 294.66K | -12.8% | $4.89M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 294.66K | -12.8% | $4.89M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 17 | Millennium Management ✦ | 97.94K | -91.2% | $1.63M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 67.67K | +3.8% | $1.12M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 67.67K | +3.8% | $1.12M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 67.67K | +3.8% | $1.12M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 67.67K | +3.8% | $1.12M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 67.67K | +3.8% | $1.12M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 23 | Wellington Management ✦ | 51.77K | -7.1% | $859,982 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 24 | Wellington Management ✦ | 51.77K | -7.1% | $859,982 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 25 | Wellington Management ✦ | 51.77K | -7.1% | $859,982 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 26 | Wellington Management ✦ | 51.77K | -7.1% | $859,982 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 27 | Gotham Asset Management ✦ | 34.07K | -51.3% | $565,969 | 0.0% | ▼ Trim | 4 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Keine neu erfassten Käufer in diesem Quartal. |
Ausgestiegen
| Keine erfassten Ausstiege in diesem Quartal. |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 337 Inhaber, 164.47M Anteile, $3.62B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.